Oral manifestations of HIV: analysis of oropharyngeal candidiasis as an immunological marker

Joaquin Edgardo Torres and Virginia Marta Jewtuchowicz

South Health and Policy, 2024, vol. 3, 141-141

Abstract: Oropharyngeal candidiasis (OPC) is a highly prevalent fungal infection in immunosuppressed patients, especially those infected with human immunodeficiency virus (HIV). Candida albicans has been described as the main etiological agent, capable of changing its morphology to facilitate invasion of the oral mucosa. The onset of OP was found to be closely related to low CD4+ lymphocyte levels and was recognised as an early marker of progression to AIDS. In addition, the different clinical manifestations of OP and its higher frequency in patients not receiving effective antiretroviral therapy were analysed. The research concluded that early diagnosis, immunological monitoring, and appropriate antifungal therapy were essential for improving the quality of life of HIV-positive patients. Despite advances in antiretroviral therapy, oropharyngeal candidiasis persisted as a relevant infection, especially in resource-limited settings.

Date: 2024
References: Add references at CitEc
Citations:

There are no downloads for this item, see the EconPapers FAQ for hints about obtaining it.

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:dbk:southh:2024v3a72

DOI: 10.56294/shp2024141

Access Statistics for this article

More articles in South Health and Policy from AG Editor (Argentina)
Bibliographic data for series maintained by Javier Gonzalez-Argote ().